High materiality7/10
Q32 Bio upgraded to Overweight at Wells Fargo after alopecia areata study data
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Q32 Bio (QTTB) received an upgrade to Overweight from Wells Fargo following alopecia areata study data. Target price is $66 with a posted price of $20.29. PriceChangeSinceSignal is -0.52, indicating a pullback since the signal.
- Wells Fargo upgrades QTTB to Overweight
- Target $66; price $20.29; priceChange -0.52
Key facts
- 01
Target: $66
- 02
Posted price: $20.29
- 03
Analyst firm: Wells Fargo
- 04
Analyst: Derek Archila
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.